Prevention of acute upper respiratory tract inflammation by green tea gargling: concentration-dependent effects
Not Applicable
- Conditions
- Acute upper respiratory tract inflammation
- Registration Number
- JPRN-UMIN000045060
- Lead Sponsor
- Department of Drug Evaluation and Information Graduate School of Pharmaceutical Science, University of Shizuoka
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 209
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Potentially having the allergy to green tea (2)Having severe systemic chronic infectious diseases (3)Subjects diagnosed by physicians inappropriate to participate in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1 The occurrence of acute upper respiratory tract inflammation.
- Secondary Outcome Measures
Name Time Method 1 The occurrence of influenza 2 The occurrence of SARS COVID-2 3 Term from when clinical trial starts to when acute upper respiratory tract inflammation occurs 4Severity of symptoms 5Number of occurrences 6Complication such as pneumonia and encephalopathy or hospitalization 7Adverse events